Eckhard U Alt

This inventor holds 19 USPTO granted patents and 22 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Regenerative Medicine. Top assignees: Ingeneron Incorporated, The University of Texas System, Medtronic, Inc.. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eckhard U Alt. Retrieved from https://idiyas.com/inventor/eckhard-u-alt-u6wggnak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 22)

% Patents Active = 68.4

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 2.0

ph-index = 6

Forward Citations = 96(Granted Patents)

Location History:

Houston, AZ (US) (2016)
Houston, TX (US) (2012 - 2022)

Company Filing History:

11 out of 15

Ingeneron Incorporated

patents

4 out of 5,638

The University of Texas System

Alliance of Cardiovascular Research

patent

6. 1 out of 1

Alliance of Cardiovascular Researchers

patent

7. 1 out of 1

Alliance of Cardiovascular Researches

patent

8. 1 out of 3

Arthrodynamic Holdings, LLC

patents

9. 3 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2022

Loading Chart...

Areas of Expertise:

Cell Isolation

Virus Delivery

Stem Cells

Cancer Therapy

Apoptosis

Optical Assay

Hyaluronic Acid

Biomatrix Composition

Sleep Apnea

Vagal Stimulation

Impedance Measurements

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11369716 - Reparative cell isolation and delivery (2022-06-28),

2. 11020444 - Transluminal delivery of viruses for treatment of diseased tissue (2021-06-01),

3. 10905722 - Induced pacemaker and Purkinje cells from adult stem cells (2021-02-02),

4. 10760059 - Reprogrammed beta cells from adult stem cells (2020-09-01),

5. 10328056 - Priming of pancreatic tumor cells and cancer stem cells to TRAIL-induced apoptosis (2019-06-25),

6. 10238770 - Reparative cell isolation and delivery (2019-03-26),

7. 10213579 - Catheter for cell infusion and method of pressure regulation (2019-02-26),

8. 9913865 - Induced pacemaker and Purkinje cells from adult stem cells (2018-03-13),

9. 9675673 - Transluminal delivery of oncoltyic viruses for cancer therapy (2017-06-13),

10. 9593309 - Media for culturing, preserving, and administering regenerative cells (2017-03-14),

11. 9447379 - Derivation of hematopoietic cells from adult mesenchymal stem cells (2016-09-20),

12. 9310300 - Compact portable apparatus for optical assay (2016-04-12),

13. 9173975 - Reparative cell delivery via hyaluronic acid vehicles (2015-11-03),

14. 8951513 - Methods and apparatus for enhanced recovery of cells and of cell-enriched matrix from tissue samples (2015-02-10),

15. 8865199 - Biomatrix composition and methods of biomatrix seeding (2014-10-21),

Title: **Eckhard U Alt: Innovator in Medical Technologies**

Introduction

Eckhard U Alt is a prominent inventor based in Houston, Texas, renowned for his innovative contributions to medical technology. With a remarkable portfolio of 19 patents, Alt's work focuses on breakthrough methods for cell therapies and targeted drug delivery systems. His latest advancements reflect a strong commitment to enhancing patient care through novel approaches.

Latest Patents

Alt's latest patents include significant innovations such as "Reparative Cell Isolation and Delivery," which outlines methods for generating autologous tissue grafts. This process not only enriches cell populations with stem cells but also utilizes biological fillers like hyaluronic acid to localize cells and stimulate collagen production, enhancing graft viability and longevity. Another important patent, "Transluminal Delivery of Viruses for Treatment of Diseased Tissue," details methods for treating cancer by delivering oncolytic viruses through a balloon catheter. This precise delivery allows for increased concentration and control, ensuring effective therapy while minimizing risks to healthy tissues.

Career Highlights

Eckhard U Alt has made significant strides in his career, holding key positions in innovative companies such as Ingeneron Incorporated and the Massachusetts Institute of Technology (MIT). His work has often bridged the gap between research and practical applications, exemplifying the embodiment of innovation in the medical field.

Collaborations

Throughout his career, Alt has collaborated with several esteemed professionals, including Michael E Coleman and Maik Gollasch. These partnerships have further enhanced his ability to push the boundaries of medical technology and deliver impactful solutions to healthcare challenges.

Conclusion

Eckhard U Alt's contributions to medical innovations underscore the importance of inventive solutions in enhancing treatment options for patients. With an impressive array of patents and a career dedicated to research and development, he continues to be a key figure in the evolution of medical technologies. His work not only reflects technical expertise but also a profound commitment to improving patient outcomes through innovation.

Profile summary based on public USPTO records.